Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

NCT02021032 is registered in ClinicalTrials.gov with Medifocus, Inc. as lead sponsor.

NCT NCT02021032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02021032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)
Lead sponsor
Medifocus, Inc.
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2006
Completion date
August 31, 2018
Enrollment
250 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostate hyperplasia